Back to search
FDAFDA · Food and drugs·Recall number D-1325-2022

Racepinephrine Inhalation Solution, USP 2.25%, Bronchodilator, For Oral Inhalation Only, Sulfite Free, Preservative Free, 30 x 0.5 mL Sterile Unit-of-Use Vials, each in a foil pouch, per carton, Nephron Pharmaceuticals Corporation, NDC 0487-5901-99.

Published August 17, 2022 · Recall initiated: June 29, 2022

Summary

FDA records drug Class II recall D-1325-2022, published August 17, 2022 and initiated June 29, 2022. Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office; Status: Terminated; Reported quantity: 23 cartons. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: products were stored outside the drug label specifications.

What to do

Voluntary: Firm initiated · Letter

Get an email if S2 has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
S2
Manufacturer
Mckesson Medical-Surgical Inc. Corporate Office
Distributor
Nationwide in the USA.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Racepinephrine Inhalation Solution, USP 2.25%, Bronchodilator, For Oral Inhalation Only, Sulfite Free, Preservative Free, 30 x 0.5 mL Sterile Unit-of-Use Vials, each in a foil pouch, per carton, Nephron Pharmaceuticals Corporation, NDC 0487-5901-99. recalled?

Yes. FDA published recall D-1325-2022 on August 17, 2022. Reported hazard: CGMP Deviations: products were stored outside the drug label specifications.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: S2.